Kura Oncology, Inc. · NASDAQ:KURA
BVF PARTNERS L P/IL's stake in Kura Oncology, Inc. fell to 4.30% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 4, 2025
BVF PARTNERS L P/IL's stake in Kura Oncology, Inc. fell to 4.30%, 3,408,054 shares, as a passive investor on Dec 31, 2024. Filed Feb 4, 2025 (Schedule 13G/A).
- Stake
- 4.30%
- Shares
- 3,408,054
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 2.20% | 1,751,852 |
| BVF I GP LLC | 2.20% | 1,751,852 |
| BIOTECHNOLOGY VALUE FUND II LP | 1.80% | 1,410,347 |
| BVF II GP LLC | 1.80% | 1,410,347 |
| Biotechnology Value Trading Fund OS LP | 0.20% | 177,882 |
| BVF Partners OS Ltd. | 0.20% | 177,882 |
| BVF GP HOLDINGS LLC | 4.00% | 3,162,199 |
| BVF PARTNERS L P/IL | 4.30% | 3,408,054 |
| BVF INC/IL | 4.30% | 3,408,054 |
| LAMPERT MARK N | 4.30% | 3,408,054 |
Source
Related
- Kura Oncology, Inc.
- Bvf Partners L P
- Kura Oncology, Inc. shareholders
- Schedule 13G/A · Bvf Partners L P · Nov 14, 2025
- Schedule 13G · Bvf Partners L P · Feb 4, 2025
- Form 4 · Ford Kathleen · Sep 29, 2026
- Form 4 · Leoni Mollie · Sep 29, 2026
- Form 4 · Powl Brian T. · Sep 29, 2026
- Form 4 · Bair Teresa Brophy · Sep 29, 2026
- Form 4 · Doyle Thomas James · Sep 29, 2026